Ovid Therapeutics Inc (OVID)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1460 BROADWAY NEW YORK, NY 10036

Ovid Therapeutics Inc. operates as a biopharmaceutical company. The Company focuses on developing medicines for patients and families living with rare neurological disorders. Ovid Therapeutics offers its services in the United States.

Data based on most recent fiscal year report
Market Cap154.488 Million Shares Outstanding24.6 Million Avg Volume94.73 Thousand
View SEC Filings from OVID instead.
Q4 2018 All Institutions Hedge Funds 1
To trade OVID now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 48 6 (0.59%)
Aggregate 13F shares on 12/31/2018: 6.836 Million 2.486 Million
Aggregate 13F shares on 09/30/2018: 7.39 Million 1.195 Million
Percent change: -7.49% 107.93%
Funds creating new positions: 9 4
Funds Adding to an existing position: 13 1
Funds closing out their position: 11 5
Funds reducing their position: 16 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding OVID (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

85 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DUNCAN BARBARA GAYLE

  • Director
0 2019-03-05 1

BERNSTEIN KAREN

  • Director
20,000 2019-02-26 3

DALY TIMOTHY SVP,FINANCE & CORP. CONTROLLER

  • Officer
0 2019-02-24 2

DURING MATTHEW PRESIDENT AND CSO

  • Officer
  • Director
  • 10% Owner
0 2019-02-24 1

HAASNER DIRK SVP, GLOBAL REGULATORY AFFAIRS

  • Officer
0 2019-02-24 2

RAKHIT AMIT CMO AND PMO

  • Officer
0 2019-02-24 2

WARD ANA SVP AND GENERAL COUNSEL

  • Officer
0 2019-02-24 2

LEVIN JEREMY M CEO

  • Officer
  • Director
  • 10% Owner
5,177,106 2019-02-22 1

FRIEDMAN BART

  • Director
0 2018-12-11 1

WILLIAMS DOUGLAS E

  • Director
5,000 2018-08-14 2

WERBER YARON CBO, CFO, SEC. AND TREAS.

  • Officer
0 2018-01-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BERNSTEIN KAREN - Director

2019-02-26 P 10,000 $2.02 a 20,000 20,000.00 direct

DURING MATTHEW - Director - Officer - > 10% Owner PRESIDENT AND CSO

2019-02-24 A 70,000 a 70,000 0.00 direct

DALY TIMOTHY - Officer SVP,FINANCE & CORP. CONTROLLER

2019-02-24 A 50,000 a 50,000 0.00 direct

LEVIN JEREMY M - Director - Officer - > 10% Owner CEO

2019-02-24 A 250,000 a 250,000 5,177,106.00 direct

WARD ANA - Officer SVP AND GENERAL COUNSEL

2019-02-24 A 40,000 a 40,000 0.00 direct

RAKHIT AMIT - Officer CMO AND PMO

2019-02-24 A 125,000 a 125,000 0.00 direct

HAASNER DIRK - Officer SVP, GLOBAL REGULATORY AFFAIRS

2019-02-24 A 75,000 a 75,000 0.00 direct

LEVIN JEREMY M - Director - Officer - > 10% Owner CEO

2019-02-22 P 75,000 $2.00 a 4,676,529 5,177,106.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments